Alpha-aminoamide derivatives as melanocortin agonists
US6916812B2 · kind B2 · utility
9Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2002 |
| Grant date | Jul 12, 2005 |
| Priority date | — |
| Expiry date | Apr 3, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel piperazine and homopiperazine derivatives are agonists of melanocortin receptor(s) and are useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of the melanocortin receptors. The compounds of the present invention are therefore useful for treatment or prevention of diseases and disorders such as obesity, diabetes, and sexual dysfunction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.